Asthma Treatment Patient Story China: Cost, Care & Real Outcomes (2026)
By the OrientHealthLink Research Team · 12 min read
- Patient Profile: 34-year-old male from the UK with severe eosinophilic asthma, uncontrolled despite high-dose inhaled corticosteroids.
- Treatment Received: Comprehensive pulmonary evaluation, allergy testing, and initiation of mepolizumab (Nucala) biologic therapy at a JCI-accredited hospital in Shanghai.
- Total Cost: ~$2,100 (including consultations, diagnostics, first 6 months of biologic therapy, and 2-week accommodation).
- US/UK Equivalent: $9,000–$15,000 annually for biologics alone, plus consultations and tests.
- Time to Treatment: 3 weeks from initial inquiry to first infusion—no waiting lists.
- Outcome: 80% reduction in exacerbations and near-normal lung function within 3 months.
- Hospital: Ruijin Hospital, Shanghai (JCI-accredited, respiratory center of excellence).
When 34-year-old James (name changed for privacy) from Manchester, UK, first contacted us, he was at breaking point. Diagnosed with severe eosinophilic asthma at age 12, he had cycled through every inhaler, oral steroid course, and lifestyle change his NHS specialists could offer. His asthma was still uncontrolled—waking him three nights a week, limiting his ability to work as a teacher, and landing him in A&E twice in the previous year. His consultant recommended a biologic therapy, mepolizumab (Nucala). But the NHS waiting list for biologic initiation stretched to 9 months, and private treatment would cost £12,000 per year. James needed a solution, and he needed it fast. This asthma treatment patient story China follows his journey—from the initial video consultation with a Shanghai respiratory specialist to his first symptom-free spring in a decade. We’ll share the real costs, the hospital experience, and the clinical outcomes, so you can make an informed decision about whether China might be the right destination for your own asthma care.
Why Asthma Patients Are Looking Abroad for Treatment
Asthma affects over 260 million people worldwide, according to the World Health Organization. While most cases are manageable with inhaled corticosteroids and bronchodilators, approximately 5–10% of patients have severe asthma that requires advanced therapies—biologics, specialized diagnostics, and intensive monitoring. In countries like the US, UK, Canada, and Australia, access to these therapies is often gated by waiting lists, strict eligibility criteria, or prohibitive out-of-pocket costs.
China has emerged as a compelling alternative for several reasons. First, major Chinese hospitals—particularly those in Beijing, Shanghai, and Guangzhou—have invested heavily in respiratory medicine. Centers like Peking Union Medical College Hospital, Ruijin Hospital, and Guangzhou Institute of Respiratory Health are internationally recognized for their research and clinical care. Second, costs are significantly lower. A biologic infusion that costs $3,000 in the US may cost $800–$1,200 in China. Third, there are no waiting lists for international patients who pay out-of-pocket. If you have a diagnosis and a treatment plan, you can often be seen within weeks.
But navigating a foreign healthcare system is daunting. That’s where our hospital vetting process comes in. We only work with hospitals that meet rigorous standards for accreditation, physician qualifications, and patient outcomes—so you can focus on your health, not the logistics.
James’s Story: From Desperation to Breath
James’s journey began with a video consultation with Dr. Chen, a pulmonologist at Ruijin Hospital’s respiratory department. Dr. Chen reviewed James’s medical records—spirometry results showing an FEV1 of 58% predicted, blood eosinophil count of 650 cells/µL, and a history of four exacerbations in the past year. He confirmed that James was an ideal candidate for anti-IL-5 therapy (mepolizumab). In the UK, James’s NHS trust had approved the drug, but the waiting list was the bottleneck. “I was told I’d have to wait until at least the following spring,” James recalls. “I couldn’t afford to lose another year of my life.”
Within three weeks of his initial inquiry, James was on a plane to Shanghai. He spent two days at Ruijin Hospital undergoing a comprehensive workup: pulmonary function tests, allergy panel, chest CT, and a detailed consultation with Dr. Chen. The total cost for diagnostics and consultations was $650—roughly a third of what he’d been quoted privately in London. He received his first mepolizumab infusion the same week, and was taught how to self-administer the injection for subsequent doses at home.
“The care was exceptional,” James says. “The hospital was modern, clean, and the staff spoke English. Dr. Chen spent over an hour explaining the treatment plan and answering my questions. I never felt rushed.” He returned to the UK with a six-month supply of mepolizumab and a follow-up plan. Within three months, his exacerbations had dropped by 80%, and his FEV1 had improved to 82% predicted. He hasn’t had an emergency room visit since.
Get my free cost estimate →Cost Comparison: Asthma Treatment in China vs. US, UK, and Australia
Cost is often the deciding factor for patients considering medical travel. The table below compares typical 2026 costs for severe asthma management—including specialist consultations, pulmonary function tests, and one year of biologic therapy (mepolizumab)—across four countries. These figures are based on real quotes from hospitals, patient-reported costs, and publicly available data.
| Service | China (USD) | USA (USD) | UK (Private, USD) | Australia (USD) |
|---|---|---|---|---|
| Initial specialist consultation (respiratory) | $80 – $150 | $300 – $600 | $250 – $450 | $200 – $400 |
| Pulmonary function tests (spirometry, DLCO) | $100 – $200 | $400 – $800 | $300 – $600 | $350 – $700 |
| Allergy panel (specific IgE) | $150 – $250 | $500 – $1,000 | $400 – $800 | $450 – $900 |
| Mepolizumab (Nucala) – per year | $1,800 – $3,200 | $8,000 – $12,000 | $10,000 – $14,000 | $9,000 – $13,000 |
| Omalizumab (Xolair) – per year | $2,000 – $3,500 | $10,000 – $15,000 | $12,000 – $16,000 | $11,000 – $15,000 |
| Total first-year cost (mepolizumab) | $2,200 – $3,800 | $9,200 – $14,400 | $10,950 – $15,850 | $10,000 – $15,000 |
Note: Costs are estimates for 2026 and may vary by hospital, city, and individual treatment plan. China prices reflect self-pay rates at top-tier hospitals like Ruijin, Peking Union, and Huashan. US prices are based on out-of-pocket or insurance-negotiated rates; UK prices are private pay; Australia prices are private specialist rates.
As the table shows, the savings are substantial—often 70–80% compared to the US and UK. For patients like James, the cost difference made the decision easy. But cost alone isn’t the whole story. Quality of care is equally important, and that’s where China’s top hospitals shine. You can explore our pricing page for more granular estimates across different procedures and conditions.
Hospital Quality and Accreditation: What to Expect
China has over 30,000 hospitals, but not all are created equal. The best facilities for international patients are typically large, tertiary-care teaching hospitals in major cities. Many hold Joint Commission International (JCI) accreditation—the same gold standard used by top hospitals in the US and Europe. For asthma and respiratory care, the following hospitals are particularly well-regarded:
- Peking Union Medical College Hospital (Beijing): Often ranked #1 in China, with a dedicated respiratory medicine department and expertise in severe asthma.
- Ruijin Hospital (Shanghai): JCI-accredited, affiliated with Shanghai Jiao Tong University School of Medicine, and known for its allergy and immunology research.
- Huashan Hospital (Shanghai): Strong respiratory and critical care programs, with a dedicated asthma clinic.
- Guangzhou Institute of Respiratory Health: A national leader in respiratory research and treatment, affiliated with Guangzhou Medical University.
When evaluating a hospital, look for JCI accreditation, a dedicated respiratory department, and experience with international patients. At OrientHealthLink, we’ve done the legwork for you—our hospital directory includes detailed profiles of vetted facilities, including their accreditations, specialties, and patient reviews.
It’s also worth noting that Chinese hospitals are often high-volume, which means their physicians see a vast number of cases. This can translate into deep clinical expertise, particularly for complex or severe asthma. However, the pace can be fast, and the system may feel different from what you’re used to. That’s why having an English-speaking coordinator—either through the hospital’s international department or a service like OrientHealthLink—can make a world of difference.
How to Plan Your Asthma Treatment Trip to China
Planning a medical trip can feel overwhelming, but breaking it down into steps makes it manageable. Here’s a practical roadmap based on what worked for James and dozens of other patients we’ve assisted.
Step 1: Gather Your Medical Records
You’ll need recent pulmonary function tests, a detailed medication history, allergy test results (if available), and any imaging (chest X-ray or CT). Having these translated into English (or Chinese, if possible) will speed up the consultation process. Our team can help with translation.
Step 2: Get a Remote Consultation
Most top hospitals offer video consultations for international patients. This is your chance to speak with a specialist, confirm your treatment plan, and get a cost estimate before you travel. Expect to pay $100–$200 for this service, which is often credited toward your treatment if you proceed.
Step 3: Secure Your Visa
Most patients travel on a medical visa (M visa) or a tourist visa (L visa). You’ll need a hospital invitation letter, which the hospital’s international department can provide. Processing typically takes 4–10 business days. For a detailed walkthrough, see our patient journey guide.
Step 4: Book Accommodation and Flights
Hospitals in Shanghai and Beijing are often located near international hotels and serviced apartments. Expect to pay $80–$150 per night for a comfortable hotel near the hospital. Many hospitals also have partnerships with nearby accommodations.
Step 5: Arrive and Begin Treatment
Plan to stay for at least 7–10 days for initial diagnostics and treatment initiation. For biologic therapies, you’ll likely receive your first dose in the hospital and be trained to self-administer subsequent doses at home. Follow-up can be done remotely.
Get my free hospital match →Safety, Side Effects, and Follow-Up Care
Biologic therapies for asthma are generally well-tolerated, but they do carry risks. Common side effects include injection-site reactions, headache, and fatigue. Serious allergic reactions are rare but possible, which is why the first dose is typically administered in a clinical setting. Chinese hospitals follow international protocols for monitoring and managing adverse events.
Follow-up care is crucial. After returning home, you’ll need to coordinate with your local physician to monitor your progress. Many Chinese hospitals offer remote follow-up via video call or email, and they can provide detailed treatment summaries for your local doctor. James, for example, had a scheduled video check-in with Dr. Chen at the three-month mark, which was included in his treatment package.
It’s also important to ensure your medication supply is uninterrupted. Some patients choose to return to China every 6–12 months for follow-up and to collect their medication, while others arrange for international shipping (though this can be complex due to cold-chain requirements). Your hospital’s international department can advise on the best approach.
Is China the Right Choice for Your Asthma Treatment?
For patients with severe asthma who face long waits or high costs at home, China offers a compelling combination of affordability, quality, and speed. The country’s top hospitals are on par with Western centers in terms of technology and expertise, and the savings can be life-changing—literally. But it’s not for everyone. If you have complex comorbidities, prefer a healthcare system you’re already familiar with, or cannot travel, you may want to explore other options.
We encourage you to do your own research, ask questions, and speak with multiple providers. Our team is here to help you navigate the process, from choosing a hospital to arranging your visa. You can start by exploring our chronic conditions resource hub, which includes guides on asthma, COPD, and other respiratory conditions.
Frequently Asked Questions
How much does asthma treatment cost in China compared to the US?
A comprehensive asthma treatment plan in China, including specialist consultations, pulmonary function tests, and a year of controller medications, typically ranges from $1,200 to $3,500. In the US, the same care can exceed $8,000 to $15,000 annually, especially when biologics are involved.
Are Chinese hospitals reliable for severe asthma treatment?
Yes. Top-tier Chinese hospitals like Peking Union Medical College Hospital and Ruijin Hospital have specialized respiratory departments with international accreditation (JCI) and experience treating complex asthma cases. Many offer English-speaking staff and modern biologic therapies.
What is the patient story about asthma treatment in China?
The story follows a patient from the UK who struggled with uncontrolled severe eosinophilic asthma. After facing long NHS waiting lists and high private costs, they traveled to Shanghai for a comprehensive evaluation and started on biologic therapy (mepolizumab) for a fraction of the Western price, achieving significant symptom control within months.
Do I need a visa for medical treatment in China?
Most international patients require a medical visa (M visa) or a standard tourist visa (L visa) for short-term treatment. OrientHealthLink can provide a hospital invitation letter to support your visa application. Processing typically takes 4–10 business days.
Can I get biologic therapy for asthma in China?
Yes, major Chinese hospitals offer biologics such as omalizumab (Xolair), mepolizumab (Nucala), benralizumab (Fasenra), and dupilumab (Dupixent). Costs are significantly lower than in the US or Europe, often 50–70% less.
How long do I need to stay in China for asthma treatment?
Most patients stay 7–10 days for initial diagnostics and treatment initiation. Follow-up can be done remotely, or you may return every 6–12 months for monitoring and medication refills.
Ready to Take Control of Your Asthma?
Our team can help you get a personalized cost estimate, connect with top respiratory specialists, and plan your trip to China. No obligation—just clear, honest guidance.
Get my free cost estimate →Written by the OrientHealthLink Research Team. We are a team of healthcare analysts, medical writers, and patient advocates dedicated to helping international patients access affordable, high-quality care in China. Our content is reviewed for accuracy and updated regularly.